Identiv completed the sale of its specialty Internet of Things Business for $50 million of Trackonomy Systems preferred stock valued at $20.07 per share, alongside $25 million in cash. Investors also face a corporate name change effective immediately and an interim CEO transition beginning September 21, 2026.

Key Highlights

  • Identiv shareholders approved the Stock and Asset Sale with 17,581,408 votes for and 5,539,132 against.
  • INVE Technologies will replace Identiv, Inc. as the corporate name effective September 15, 2026.
  • Identiv received $50 million of Trackonomy Systems Series C Preferred Stock, valued at $20.07 per share at closing.
  • Stockholders approved the transaction at the September 10, 2026 annual meeting, with 17,581,408 votes for and 5,539,132 against.

Identiv (NASDAQ: INVE) received $50 million of Trackonomy Systems Series C Preferred Stock, valued at $20.07 per share at closing.

Sale Terms Set At Closing

The transaction was completed under a Stock and Asset Purchase Agreement dated June 24, 2026. The consideration remains subject to customary adjustments, which are to be made 90 days after closing and remain subject to customary dispute procedures. Trackonomy Systems is a Delaware corporation. Identiv’s Thailand Subsidiary was wholly owned before the transaction and formed part of the Assets transferred in the sale. The deal received stockholder approval at the annual meeting held on September 10, 2026. The resolution passed with 17,581,408 votes for, 5,539,132 against, 880,225 abstentions and 3,255,471 broker non-votes. Stockholders also approved compensation that may be paid or become payable to named executive officers in connection with the transaction. That vote recorded 11,025,047 votes for, 5,772,838 against, 23,257 abstentions and 3,255,471 broker non-votes.

Corporate Name Changes

The Board approved the change on September 11, 2026, subject to completion of the asset sale. A stockholder vote was not necessary for the name change under Delaware law, and the change does not affect stockholder rights. The amended bylaws also took effect on September 15, 2026, reflecting the new corporate name. The annual meeting elected Laura Angelini, Richard E. Kuntz, M.D. Miguel A. Lopez, Kirsten F. Newquist and James E. Ousley to one-year terms ending at the 2027 annual meeting, unless their service ends earlier through death, resignation or removal. The vote totals for the director nominees were 10,317,467 for and 6,503,675 withheld for Angelini; 10,806,634 for and 6,014,508 withheld for Kuntz; 11,563,119 for and 5,258,023 withheld for Lopez; 12,509,293 for and 4,311,849 withheld for Newquist; and 10,581,084 for and 6,240,058 withheld for Ousley. Each nominee also had 3,255,471 broker non-votes.

Interim CEO Starts September 21

Newquist will resign from the Board effective September 30, 2026. The Leadership changes follow completion of the business sale and the corporate name change. The measure received 10,642,506 votes for, 6,156,547 against, 22,089 abstentions and 3,255,471 broker non-votes. Named executive officer compensation received 10,087,173 votes for, 6,731,294 against, 2,675 abstentions and 3,255,471 broker non-votes on a non-binding advisory basis.